Publications of the SFB 1321

Publications



Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects


Adam, M. G., Beyer, G., Christiansen, N., Kamlage, B., Pilarsky, C., Distler, M., Fahlbusch, T., Chromik, A., Klein, F., Bahra, M., Uhl, W., Grutzmann, R., Mahajan, U. M., Weiss, F. U., Mayerle, J., and Lerch, M. M. (2021). Gut [Epub ahead of print]

Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA


Niu, G., Hellmuth, I., Flisikowska, T., Pausch, H., Rieblinger, B., Carrapeiro, A., Schade, B., Bohm, B., Kappe, E., Fischer, K., Klinger, B., Steiger, K., Burgkart, R., Bourdon, J. C., Saur, D., Kind, A., Schnieke, A., and Flisikowski, K. (2021). Oncogene [Epub ahead of print]

The SUMO pathway in pancreatic cancer: insights and inhibition


Schneeweis, C., Hassan, Z., Schick, M., Keller, U., and Schneider, G. (2020). Br J Cancer [Epub ahead of print]

Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis


Pergolini, I., Schorn, S., Jager, C., Goss, R., Novotny, A., Friess, H., Ceyhan, G. O., and Demir, I. E. (2021). Surgery 169, 411-418

Disorders of the enteric nervous system - a holistic view


Niesler, B., Kuerten, S., Demir, I. E., and Schafer, K. H. (2021). Nat Rev Gastroenterol Hepatol [Epub ahead of print]

Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer


Goess, R., Mutgan, A. C., Calisan, U., Erdogan, Y. C., Ren, L., Jager, C., Safak, O., Stupakov, P., Istvanffy, R., Friess, H., Ceyhan, G. O., and Demir, I. E. (2021). Cancers (Basel) 13

Data-independent acquisition method for ubiquitinome analysis reveals regulation of circadian biology


Hansen, F. M., Tanzer, M. C., Bruning, F., Bludau, I., Stafford, C., Schulman, B. A., Robles, M. S., Karayel, O., and Mann, M. (2021). Nat Commun 12, 254

Mesenchymal plasticity regulated by Prrx1 drives aggressive pancreatic cancer biology


Feldmann, K., Maurer, C., Peschke, K., Teller, S., Schuck, K., Steiger, K., Engleitner, T., Ollinger, R., Nomura, A., Wirges, N., Papargyriou, A., Jahan Sarker, R. S., Ranjan, R. A., Dantes, Z., Weichert, W., Rustgi, A. K., Schmid, R. M., Rad, R., Schneider, G., Saur, D., and Reichert, M. (2020). Gastroenterology 160, 346-361 e324

Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms


Pergolini, I., Jager, C., Safak, O., Goss, R., Novotny, A., Ceyhan, G. O., Friess, H., and Demir, I. E. (2020). Clin Gastroenterol Hepatol 19, 171-179

Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation


Pfitzinger, P. L., Fangmann, L., Wang, K., Demir, E., Gurlevik, E., Fleischmann-Mundt, B., Brooks, J., D'Haese, J. G., Teller, S., Hecker, A., Jesinghaus, M., Jager, C., Ren, L., Istvanffy, R., Kuhnel, F., Friess, H., Ceyhan, G. O., and Demir, I. E. (2020). J Exp Clin Cancer Res 39, 289